Plasma Rich in Growth Factors (PRGF) Treatment for Muscle Tear

Phase 3CompletedNCT00726245

Meir Medical Center50 enrolled

Overview

the improvement of symptoms and disease progress by the treatment of OA of the knee with PRGF

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

PRGFBIOLOGICAL

3-6mg IM (to area of muscle tear)

PlaceboBIOLOGICAL

3cc IM of physiological saline

Sex: ALLMin age: 15 YearsMax age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * US diagnosed muscle tear * age 15-40 years old Exclusion Criteria: * pregnancy * mental or physical disabilities

Meir Medicak Center

Kfar Saba, Israel

improvement of symptoms / disease progress

Time frame: 1 year

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.